Cosmo Bio Co (TSE:3386) Cash Flow for Dividends: 円-348 Mil (TTM As of Dec. 2025)


TSE:3386 Cosmo Bio Co Ltd TSE:3386
73 GF Score
Price 円1,262.00
GF Value 円1,246.90
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Cosmo Bio Co Cash Flow for Dividends?

Cosmo Bio Co TSE:3386 -0.55% 73 Cash Flow for Dividends is 円-348 Mil as of Dec. 2025. GuruFocus rates TSE:3386 with a GF Score™ of 73/100 and a GF Value™ of 円1,246.90 (Fairly Valued). The stock has 4 warning signs investors should review.

Cosmo Bio Co's cash flow for dividends for the six months ended in Dec. 2025 was 円-142 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2025 was 円-348 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Cosmo Bio Co's quarterly payment of dividends increased from Dec. 2024 (円-82 Mil) to Jun. 2025 (円-206 Mil) but then declined from Jun. 2025 (円-206 Mil) to Dec. 2025 (円-142 Mil).

Cosmo Bio Co's annual payment of dividends declined from Dec. 2023 (円-197 Mil) to Dec. 2024 (円-175 Mil) but then increased from Dec. 2024 (円-175 Mil) to Dec. 2025 (円-348 Mil).

Cosmo Bio Co Cash Flow for Dividends Related Terms

Cosmo Bio Co Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for Cosmo Bio Co's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cosmo Bio Co Cash Flow for Dividends Chart

Cosmo Bio Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only -223.00 -232.00 -197.00 -175.00 -348.00

Cosmo Bio Co Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -81.00 -93.00 -82.00 -206.00 -142.00
TSE:3386
73GF Score
Cosmo Bio Co Ltd TSE:3386
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cosmo Bio Co Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was 円-348 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of 円-348 Mil mean?
Cosmo Bio Co (TSE:3386) has a Cash Flow for Dividends of 円-348 Mil as of Dec. 2025. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Cosmo Bio Co and its competitors.
Is Cosmo Bio Co's Cash Flow for Dividends too high?
Cosmo Bio Co's current Cash Flow for Dividends is 円-348 Mil. Overall, Cosmo Bio Co has a GF Score™ of 73/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cosmo Bio Co's Cash Flow for Dividends compare to TMO and DHR?
Cosmo Bio Co's Cash Flow for Dividends of 円-348 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Medical Diagnostics & Research company?
A good Cash Flow for Dividends depends on the Medical Diagnostics & Research industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Cosmo Bio Co and its competitors. Cosmo Bio Co's current Cash Flow for Dividends is 円-348 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cosmo Bio Co stock overvalued right now?
Based on GuruFocus' analysis, Cosmo Bio Co (TSE:3386) is currently considered Fairly Valued. The stock's GF Value™ is 円1,246.90, compared to a current price of 円1,262.00 — trading 1.2% above its estimated fair value. The current Cash Flow for Dividends is 円-348 Mil. Cosmo Bio Co's overall GF Score™ is 73/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Cosmo Bio Co (TSE:3386), the current Cash Flow for Dividends is 円-348 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cosmo Bio Co (TSE:3386) Overvalued in 2026?

Based on GuruFocus' analysis, Cosmo Bio Co stock appears to be overvalued. The current stock price of 円1,262.00 is trading 1.2% above its estimated GF Value™ of 円1,246.90. GuruFocus considers Cosmo Bio Co to be Fairly Valued.

Key valuation signals for TSE:3386:

  • Cash Flow for Dividends: 円-348 Mil
  • GF Value™: 円1,246.90 vs. price of 円1,262.00 (1.2% above fair value)
  • GF Score™: 73/100 with 4 warning signs

No single metric tells the full story. See the TSE:3386 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cosmo Bio Co Business Description

Address 2-20, Toyo-Ekimae Building, Toyo 2-Chome, Koto-ku, Tokyo, JPN, 135-0016
Cosmo Bio Co Ltd is a diagnostic and research company based in Japan. The business of the company includes the purchase of reagents, instruments, and clinical test drugs for research in life science and domestic sales.
73GF Score

Get the complete analysis for TSE:3386

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,262.00
Price
円1,246.90
GF Value